News

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
After a more than decade-long process to bring the experimental drug elamipretide to market, the treatment’s approval has ...
FDA Commissioner Marty Makary has launched a series of ad hoc “expert panels” to discuss antidepressants, menopause drugs, ...
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...
Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...
The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...
The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...
Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...
The U.S. Food and Drug Administration (FDA) is proposing an update to a decades-old orange juice rule that could give ...
After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational ...
Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...
A new study shows access to birth control has increased following the FDA's approval of an over-the-counter birth control pill. In the two years since the pill went on the market, there's a 31.8% ...